Form D · Other Health Care

General Fluidics Corp

Waltham, MA · CIK 0001755195

Offering snapshot reported Jul 31, 2024 · SEC filing

Reported sold
$18.5M
Offering amount: $27.9M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 16, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 31, 2024Initial$18,486,488No comparison16SEC filing
Jun 30, 2023Amendment$4,100,000No comparison10SEC filing
Jun 29, 2022InitialYet to sellNo comparison0SEC filing
Dec 15, 2020Initial$6,650,000No comparison1SEC filing
Oct 4, 2018Initial$5,378,251No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0
Form D file number
021-520201
$5,000 cash and warrant to purchase 6,705 shares of Common Stock

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Wingate Asset Management LimitedNone

Source: Form D, filed Jul 31, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nancy Gagliano Director
Marc Goldberg Director
Robert Granier Director, Executive
Keith Greenfield Director
Ramin Haghgooie Director
Timothy Hirsch Director
Jason Napolitano Director
Christopher Sveen Director
Ronald Tompkins Director
Robert Warren Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1601 Trapelo Road
Waltham, MA, 02451